About Gliotem 250mg Capsule
Jump on the opportunity to experience Gliotem 250mg Capsule, an acclaimed oral oncology medicine, praiseworthy for its potent therapeutic action against malignant glioma, anaplastic astrocytoma, and glioblastoma multiforme. With each hard gelatin capsule containing blue-ribbon Temozolomide 250mg, this affordable, polished formulation is intended for once-daily use under strict medical supervision. Gliotem is not recommended during pregnancy or for pediatric patients unless specifically directed. Please note, common side effects may include nausea, fatigue, and myelosuppression. Store below 30C, protected from moisture.
Distinguished Features & Competitive Edge
Gliotem 250mg Capsule stands out for its outstanding bioavailability and patient-friendly oral route. This blue-ribbon antineoplastic agent is engineered with a polished formulation, minimizing fermentation smell and providing a consistent dose. Its hard gelatin construction ensures stability, while compliance with Indian Drug Regulatory Authority registration reinforces quality and safety. Its praiseworthy performance extends to multiple indications, supporting various oncologic protocols in brain tumor management for both hospitals and specialty clinics.
Supply Capability, Arrival & Payment Terms
With robust supply ability, Gliotem 250mg Capsule readily reaches customers across domestic markets and international destinations. Authorized distributor, exporter, supplier, and trader networks ensure swift arrival at your designated location. Payment outlay options are flexible, accommodating a range of institutional and pharmacy requirements. Gliotem is available in convenient packs of 5 capsules per strip, enabling streamlined inventory planning for clinics, hospitals, and healthcare distributors looking to optimize their oncology offerings.
FAQ's of Gliotem 250mg Capsule:
Q: How should Gliotem 250mg Capsule be administered for best results?
A: Gliotem 250mg Capsule is intended for oral administration once daily, precisely as directed by your physician. Do not alter the dosage without medical supervision.
Q: What are the primary medical indications for Gliotem 250mg Capsule?
A: Gliotem 250mg Capsule is prescribed for the treatment of malignant glioma, anaplastic astrocytoma, glioblastoma multiforme, and select brain tumors as part of anticancer chemotherapy.
Q: When should Gliotem 250mg Capsule be avoided?
A: This medication should be avoided during pregnancy and is contraindicated unless specifically prescribed for pediatric use. Discuss any risk factors with your physician prior to starting therapy.
Q: What precautions should be followed during storage of Gliotem 250mg Capsule?
A: Store Gliotem below 30C, away from moisture, in its original packaging to maintain potency and ensure patient safety throughout its 24-36 month shelf life.
Q: Where can the barcode or batch number for Gliotem 250mg Capsule be found?
A: The barcode and batch number are printed directly on the product packaging for traceability and quality assurance purposes.
Q: What are some common side effects to be aware of while using Gliotem 250mg Capsule?
A: Common side effects may include nausea, vomiting, fatigue, and myelosuppression. Promptly report any severe or unusual symptoms to your healthcare provider.